Apollon Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Apollon Wealth Management's LLY Position: Q2 2026 in Review
Apollon Wealth Management increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $1.69M and bringing the position to 67,842 shares worth $81.4M. The position accounts for 0.99% of the portfolio, ranked #15.
Apollon Wealth Management first reported a position in LLY in Q2 2020 and has held it in 23 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Apollon Wealth Management held 67,842 shares of Eli Lilly worth $81.4M as of Q2 2026.
- Apollon Wealth Management bought 1,650 Eli Lilly shares in Q2 2026, an estimated $1.69M.
- Eli Lilly made up 0.99% of Apollon Wealth Management's portfolio in Q2 2026, its #15 holding.
- Apollon Wealth Management first reported a position in Eli Lilly in Q2 2020 and has held it in 23 quarters since.
- 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.